Screening CEDM in Intermediate and High-Risk Patient Populations
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 35 - Any |
| Updated: | 3/3/2019 |
| Start Date: | February 15, 2019 |
| End Date: | February 17, 2022 |
Screening Contrast Enhanced Mammography (CEDM) in Intermediate and High-Risk Patient Populations
This research study is being done to determine if Contrast Enhanced Digital Mammography
(CEDM) can improve breast cancer detection and can be used as an additional screening method
to the standard mammographic screening.
(CEDM) can improve breast cancer detection and can be used as an additional screening method
to the standard mammographic screening.
Inclusion Criteria:
- Women aged 35 and had a negative routine mammogram within 6 months.
- Qualifies as intermediate or high-risk (>15% lifetime risk of breast cancer as defined
by IBIS version 8).
Exclusion Criteria:
- Known breast cancer
- Previously had negative MBI or MRI within 12 months of study
- Pregnant or lactating
- Contraindication to intravenous iodinated contrast
- Unable to understand or sign informed consent
- Self-reported signs or symptoms of breast cancer
We found this trial at
1
site
13400 E. Shea Blvd.
Scottsdale, Arizona 85259
Scottsdale, Arizona 85259
480-301-8000
Principal Investigator: Patel Bhavika, MD
Phone: 480-342-1335
Mayo Clinic Arizona Mayo Clinic in Arizona provides medical care for thousands of people from...
Click here to add this to my saved trials
